Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 10Other hematologic neoplasm 3Lymphoid 3Head & Neck 3Gastrointestinal 3Breast 3Myeloid 2Thoracic 1Sarcoma 1Plasma cell 1Other solid neoplasm 1Genitourinary 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 299Solid Tumors 184Advanced Solid Tumors 168Solid Tumor 152Mesothelioma, Malignant 152Mesothelioma 121Advanced Solid Tumor 97Carcinoma, Non-Small-Cell Lung 50Retinoblastoma 48Lung Neoplasms 37Solid Tumor, Adult 36Sarcoma 31Ovarian Neoplasms 29Neoplasms 27Stomach Neoplasms 26Carcinoma, Renal Cell 26Small Cell Lung Carcinoma 25Melanoma 25Pancreatic Neoplasms 24Breast Neoplasms 24Unspecified Childhood Solid Tumor, Protocol Specific 23Esophageal Neoplasms 21Uterine Cervical Neoplasms 20Solid Tumours 20Solitary Fibrous Tumor, Pleural 19Osteosarcoma 19Colorectal Neoplasms 17Neuroblastoma 16Head and Neck Neoplasms 16Carcinoma, Hepatocellular 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms, Second Primary × Other solid neoplasm × Clear all
NCT00342797 2024-03-07

Retinoblastoma Biomarker Study

National Institutes of Health Clinical Center (CC)

Completed
2,136 enrolled
DermatologicOther solid neoplasmSarcoma

Melanoma, Retinoblastoma, Sarcoma, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡